Founding Partner Program — 5 Seats. Locked Founding Rate.

The economics

$100K year 1. $250K/yr locked Founding rate by year 4.

Pricing tiers stay locked at the Founding rate for the life of the contract — future list-price increases never pass through to the founding cohort. This is an ongoing-status discount, not a one-time year-1 hook.

Year 1

$100K

vs $250K list (60% off)

Year 2

$175K

locked Founding rate (30% off)

Year 3

$175K

locked Founding rate (30% off)

Year 4+

$250K

locked Founding rate forever

Anchor: $250K list price aligns with Aetion's methodology-platform tier (the closest comp) and stays below incumbent safety-system-of-record spend (Argus / Vault Safety / LifeSphere typically $200K–$500K+ per pharma client). Rosenbound is positioned as a complementary methodology layer that sits BESIDE your system of record — not a replacement.

Year-1 sizing: $100K fits within a drug-safety director's or RWE methodology lead's discretionary evaluation budget — no C-suite procurement approval required at most pharma + CRO organizations. The year-2 ramp to $175K forces value-proof before you're paying full freight. The year-4 lock at $250K creates 4 years of customer-retention engineering baked into the deal.

What you also get

Eight Founding-Partner-only benefits beyond the price.

✓

Direct founder Slack access

Not a ticket queue, not a 24-hour SLA — a Slack channel with the founder. Real-time questions, real-time bug surfaces, real-time roadmap input.

✓

Quarterly roadmap co-input

Structured quarterly session: you bring the next two features your team needs, we prioritize one into the next quarter's roadmap. Founding Partners help shape the product trajectory.

✓

Named-reference recognition

Once the engagement goes public (your timing, your call), we list your organization as a Founding Partner with a logo on rosenbound.com. Becomes part of the procurement-credibility moat for both sides.

✓

Waived integration setup ($50K value)

Onboarding integration setup (SSO config, MedDRA license routing, cohort DSL templates for your data shape, methodology PDF customization) is included rather than billed separately at the standard $50K rate.

✓

First access to new modules

OMOP CDM ingestion (Phase 2 roadmap), E2B(R3) full import/export (Phase 1 roadmap), PSUR/PBRER signal-section exports (Phase 3 roadmap) — Founding Partners get private beta access before public release.

✓

Co-authorship on benchmarks

Rosenbound runs the full sensitivity pentagon on your in-house cohort (under your IP terms, with your approval), and the resulting methodology publication carries your team as co-authors.

✓

Vendor-security packet pre-prepared

BAA, DPA, MSA templates, one-page security overview, SOC 2 Type I status doc, pen-test result — ready for your legal review on day 1. Fast-tracks the vendor-onboarding process that typically stalls pharma deals for 4–8 weeks.

✓

Locked Founding rate for the life of the contract

When list price moves to $300K or $400K in the future, your Founding rate stays at $250K/yr. The status persists for the duration of your contract — year-7 customers are still paying year-4 Founding rates.

Who fits

Who we're selecting for.

Strong fit for the Founding Partner Program:

Drug-safety directors at top-20 pharma companies with active PSUR/PBRER/DSUR workflows
Safety leads at top-50 CROs with multi-client signal-detection responsibility
RWE methodology leads at academic medical centers running 5+ observational pharma studies annually
RWE methodology leads at top-20 CROs handling external sponsor RWE projects
Pharma RWE groups producing observational submissions to FDA, EMA, or PMDA

Less strong fit (consider waiting for public pricing): teams with no current observational-evidence or PV-triage workload; small biotech without active drug-safety operations; AMC groups without methodology lead authority.

Application process

Four steps. About three weeks. Founder-led throughout.

Initial email

Email harsh@rosenbound.com with your role, organization, and the workload you'd want the platform to support. Three sentences is enough.

30-min discovery call

Founder walks the staging product, asks about your workflow, surfaces fit/no-fit honestly. You leave knowing whether to invest further time.

Technical deep-dive

Your data-science or methodology lead joins a 60-min session walking the sensitivity pentagon + Cognitive Validation Report + audit ledger on a representative cohort.

MSA + onboarding

BAA + DPA + MSA signed (pre-prepared templates accelerate this), vendor security review completed, integration setup scheduled, first cohort uploaded within 30 days.

Five seats. Locked Founding rate. Forever.